Michael Yee | BiotechTV

top of page

Jefferies analyst Michael Yee previews the year ahead, the outlook for M&A, and dives into top picks

Jan 16, 2024

Bright Minds

Jefferies analyst Michael Yee previews the year ahead, the outlook for M&A, and dives into top picks

Michael Yee shares takeaways from last week's conference in San Francisco and highlights his top names to watch.

Jefferies’ Michael Yee joins BiotechTV for Analyst Thursdays

Aug 3, 2023

Bright Minds

Jefferies’ Michael Yee joins BiotechTV for Analyst Thursdays

Michael Yee gives his take on biotech and discusses Vertex, Ventyx Biosciences, ALX Oncology, Akero, and Prothena.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Savills' Life Sciences Overview

bottom of page

Jefferies analyst Michael Yee previews the year ahead, the outlook for M&A, and dives into top picks

Jefferies’ Michael Yee joins BiotechTV for Analyst Thursdays

Follow BiotechTV

Sponsors

Sponsor Spotlight